Lortalamine

DB09187ExperimentalSmall molecule

Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been...

Formula / weight: C₁₅H₁₇ClN₂O₂ · 292.76 g/mol (avg)
Code names: LM-1404

Resolves to

Compound

UNII9GIR4SV22TCAS70384-91-7ChEMBLCHEMBL2218922PubChem3053755KEGGD04781

Structure

InChIKeyMJRPHRMGEKCADU-UHFFFAOYSA-NSMILESCN1CCC23NC(=O)CC(C2C1)C1=CC(Cl)=CC=C1O3

What you can answer from here — as of February 21, 2021

680Drug interactionsStructured to mechanism, not free text

7+ReferencesStructured and connected to the statements they support

Which companies are running trials of Lortalamine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account